Literature DB >> 10329379

Prolactin-dependent up-regulation of BRCA1 expression in human breast cancer cell lines.

D A Favy1, P Rio, J C Maurizis, C Hizel, Y J Bignon, D J Bernard-Gallon.   

Abstract

We report experimental evidence that BRCA1, a breast and ovarian cancer susceptibility gene, is up-regulated in response to prolactin (PRL) stimulation. Expression of the BRCA1 gene was monitored in 2 human breast cancer cell lines (MCF-7 and T-47D) and in the normal mammary epithelial cell line MCF10a. Using competitive RT-PCR, we have shown that PRL induced an increase in BRCA1 mRNA level in MCF-7 and T-47D cell lines at a dose resulting in the maximal enhancement of cell proliferation. The up-regulation was 12-fold in MCF-7 cells and 2-fold in T-47D cells. No increase in BRCA1 mRNA level was observed in the MCF10a cell line. The level of BRCA1 protein was quantified using an affinity chromatography strategy. At the protein level, PRL treatment induced a 4-fold increase of BRCA1 protein expression in MCF-7 and a 6-fold increase in T-47D cells, whereas BRCA1 protein expression was not affected by PRL in MCF10a. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329379     DOI: 10.1006/bbrc.1999.0602

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

Review 1.  Using gene expression arrays to elucidate transcriptional profiles underlying prolactin function.

Authors:  Sandra Gass; Jessica Harris; Chris Ormandy; Cathrin Brisken
Journal:  J Mammary Gland Biol Neoplasia       Date:  2003-07       Impact factor: 2.673

2.  Controversial BRCA1 allelotypes in commonly used breast cancer cell lines.

Authors:  Sivasundaram Karnan; Morassa Mohseni; Yuko Konishi; Akina Tamaki; Yoshitaka Hosokawa; Ben H Park; Hiroyuki Konishi
Journal:  Breast Cancer Res Treat       Date:  2009-07-08       Impact factor: 4.872

Review 3.  Regulation of BRCA1 expression and its relationship to sporadic breast cancer.

Authors:  Christopher R Mueller; Calvin D Roskelley
Journal:  Breast Cancer Res       Date:  2002-11-13       Impact factor: 6.466

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.